Boardroom Alpha
Boardroom Alpha
AFG · Current Report (Form 8-K) · Filed December 5, 2025

American Financial Group Inc — Current Report (Form 8-K)

Form
8-K
Filed
December 5, 2025
Period
Dec 3, 2025
Ticker
AFG
Accession
0001140361-25-044459
Boardroom Alpha · Filing insights

Board approves new share repurchase program for up to 5,000,000 shares, replacing the prior program through 2030.

Buyback authorized
About American Financial Group Inc
Market cap
$10.7B
1Y TSR
+12.8%
3Y TSR
+11.0%
Board grade
B-
Sector
Financial Services
CEO
S Craig Lindner
Last annual meeting: May 20, 2026 · View full American Financial Group Inc profile →

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 OR 15(d) of
The Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported):  December 3, 2025
 
AMERICAN FINANCIAL GROUP, INC.
 (Exact name of registrant as specified in its charter)

 Ohio
1-13653
31-1544320
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)

301 East Fourth Street, Cincinnati, OH
 
45202
(Address of principal executive offices)
 
(Zip Code)

Registrant’s telephone number, including area code:  (513) 579-2121
 
(Former name or former address, if changed since last report.)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company         ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Trading
Symbol(s)
 
Name of each exchange on
which registered
 
Common Stock
 
AFG
 
New York Stock Exchange
 
5.875% Subordinated Debentures due March 30, 2059
 
AFGB
 
New York Stock Exchange
 
5.125% Subordinated Debentures due December 15, 2059
 
AFGC
 
New York Stock Exchange
 
5.625% Subordinated Debentures due June 1, 2060
 
AFGD
 
New York Stock Exchange
 
4.5% Subordinated Debentures due September 15, 2060
 
AFGE
 
New York Stock Exchange



Item 8.01
Other Events.
 
On December 3, 2025, the Board of Directors of American Financial Group, Inc. (the “Company”) approved a new share repurchase program authorizing the repurchase of up to 5,000,000 shares of the Company’s common stock from time to time on the open market (including through the use of trading plans intended to qualify under Rule 10b5-1 under the Securities Exchange Act of 1934, as amended), in privately negotiated transactions or by other methods in accordance with federal securities laws and other restrictions, at the Company’s discretion. The Company’s new share repurchase program, which will expire following December 31, 2030, will replace the current share repurchase program, which is scheduled to expire after December 31, 2025. The timing and amount of any shares repurchased under the program will be determined by the Company’s management based on its evaluation of market and business conditions and other factors. The Company is not obligated to repurchase any specific amount of shares of common stock.

Item 9.01
Financial Statements and Exhibits.
 
 
(d)
Exhibits.
 
104
Cover page Interactive Date File (embedded within Inline XBRL document).

2

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 

AMERICAN FINANCIAL GROUP, INC.

   
Date: December 5, 2025 By:
/s/  Joseph C. Alter

 
Joseph C. Alter

 
Vice President, Deputy General Counsel & Secretary


3

From this filing to the watchlist

Catch material events the day they file.

Boardroom Alpha's monitors flag CEO/CFO transitions, restatements, going-concern risk, auditor changes, and 8-K events the day they hit EDGAR — across 6,000+ U.S. public companies. Daily digest by watchlist, API-accessible.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from American Financial Group Inc (AFG)

Reference

Frequently asked questions

When did American Financial Group Inc file this 8-K?
American Financial Group Inc (AFG) filed this Current Report (Form 8-K) with the SEC on December 5, 2025. The accession number assigned by EDGAR is 0001140361-25-044459.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Board approves new share repurchase program for up to 5,000,000 shares, replacing the prior program through 2030. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What events did Boardroom Alpha flag in this filing?
BA's event-extraction layer identified this signal in the filing text: "Buyback authorized". It appears above the filing body as a labeled pill.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find American Financial Group Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K American Financial Group Inc has filed under CIK 1042046, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer